News and Events:
In 2011, Prospect signed distribution agreements for Australia. The company is currently negotiating distribution agreements for Japan and Europe.
In 2010, Prospect signed distribution agreements for Singapore, Taiwan, South Korea, and China.
Prospect Biosystems, Inc. engages in the development, manufacturing, and marketing of instrumentation, reagents, consumables, and assays for bioanalytical research and molecular pathology. Prospect’s proprietary Edge™ technology provides a powerful tool to enhance and accelerate life sciences research, pharmaceutical product development, clinical and molecular diagnostics and pathology.
Edge™ platform is a breakthrough bioanalytical fractionation and separation technology that allows scientists, researchers, medical experts, including physicians and surgeons, involved in:
Prospect ... “Outlook for future success”